We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Trial for Evaluating Sage-Based Mouthrinse

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02830802
Recruitment Status : Recruiting
First Posted : July 13, 2016
Last Update Posted : May 10, 2017
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Study Description
Brief Summary:

The investigators aim to evaluate a sage-based mouthrinse (Dr. Hauschka Med, Mundspülung Salbei) whether it is less or equal effective in alleviating inflammatory signs of intra-oral mucosa and gingiva than an water/alcohol-based taste adjusted placebo in patients dependent on ADL.

Randomization in treatment A (mouthwash with active agent, n=24) or treatment B (placebo mouthwash, n=24) Supervised use of mouthwash A or mouthwash B over 6 weeks 1x/day additional to habitual oral hygiene protocol.

The main outcome parameter will be Sulcus Bleeding Index SBI.


Condition or disease Intervention/treatment
Stomal Bleeding Stomatitis, Denture Tooth Staining Satisfaction Other: Dr. Hauschka Med Mundspüllösung Salbei / cosmetics Other: Placebo

Detailed Description:

A sage-based mouthrinse based on an extract from Salvia officinalis in a composition with extracts from Althaea Officinalis, Aesculus Hippocatanum Bark and essential oils might comprise an alternative to conventional antimicrobial mouthrinses, which might exhibit important side effects. Thus the aim of the current study is to test the null-hypothesis H0:

A sage-based mouthrinse (Dr. Hauschka Med, Mundspülung Salbei, WALA Heilmittel GmbH, Dorfstraße 1, 73087 Bad Boll/Eckwälden, Germany) is less or equal effective in alleviating inflammatory signs of intra-oral mucosa and gingiva than an water/alcohol-based taste adjusted placebo.

The placebo and the sage-based mouthrinse will be manufactured according to EU-Kosmetik-Verordnung 1223/2009 and provided by WALA Heilmittel GmbH, Dorfstraße 1, 73087 Bad Boll/Eckwälden, Germany together with the necessary safety documentation. The placebo will be an alcohol/ water based solution with a similar taste to the tested mouthrinse.

The main outcome parameter will be Sulcus Bleeding Index SBI. Among others, the main secondary outcome parameters will be Oral Health Related Quality of Life as assessed with the OHIP-14 G questionnaire, the Xerostomia inventory and a Tooth staining index.


Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 48 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Treatment
Official Title: Randomized Controlled Clinical Trial for Evaluating a Sage-based Mouthrinse in Regard to Its Anti-inflammatory Potential in Elderly Patients Which Are Dependent in Their ADLs
Study Start Date : October 2016
Estimated Primary Completion Date : October 2017
Estimated Study Completion Date : April 2018
Arms and Interventions

Arm Intervention/treatment
Experimental: Group A
Active Agent
Other: Dr. Hauschka Med Mundspüllösung Salbei / cosmetics

Supervised use over 6 weeks 1x/day additional to habitual oral hygiene protocol.

For an application fill the closure cap with the mouthwash. Rinse the mouth vigorously for 30 seconds, for easier timekeeping use the hourglass. Then spit out the mouthwash, do not rinse.

Placebo Comparator: Group B
Placebo
Other: Placebo

Supervised use over 6 weeks 1x/day additional to habitual oral hygiene protocol.

For an application fill the closure cap with the mouthwash.



Outcome Measures

Primary Outcome Measures :
  1. Sulcus Bleeding Index [ Time Frame: six weeks ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Able to give informed consent, i.e. no legal guardian appointed
  • Willing to participate
  • Depended on their ADLs (IADL)(24)
  • Sulcus Bleeding Index (SBI) > 50%

Exclusion Criteria:

  • Allergy to one of the components
  • Edentulous
  • Alcohol dependency
  • Prescription of antibiotics and/ or immunosuppressives (e.g. glucocorticoids) Anti-inflammatory mouthrinse -
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02830802


Contacts
Contact: Martin Schimmel, Prof. +4131 6322597 martin.schimmel@zmk.unibe.ch
Contact: Hendrik Juenger, Dr. +4131 7477025

Locations
Switzerland
University of Bern Recruiting
Bern, Switzerland, 3010
Contact: Martin Schimmel, Prof.    +41316322597    martin.schimmel@zmk.unibe.ch   
Sponsors and Collaborators
University of Bern
WALA Heilmittel GmbH
Investigators
Study Chair: Martin Schimmel, Prof. University of Bern
More Information

Responsible Party: University of Bern
ClinicalTrials.gov Identifier: NCT02830802     History of Changes
Other Study ID Numbers: gerodont_3: Sage Trial
First Posted: July 13, 2016    Key Record Dates
Last Update Posted: May 10, 2017
Last Verified: May 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Stomatitis
Tooth Discoloration
Stomatitis, Denture
Mouth Diseases
Stomatognathic Diseases
Tooth Diseases